Cargando…
Crowdsourced identification of multi-target kinase inhibitors for RET- and TAU- based disease: The Multi-Targeting Drug DREAM Challenge
A continuing challenge in modern medicine is the identification of safer and more efficacious drugs. Precision therapeutics, which have one molecular target, have been long promised to be safer and more effective than traditional therapies. This approach has proven to be challenging for multiple rea...
Autores principales: | , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483411/ https://www.ncbi.nlm.nih.gov/pubmed/34520464 http://dx.doi.org/10.1371/journal.pcbi.1009302 |
_version_ | 1784577120023871488 |
---|---|
author | Xiong, Zhaoping Jeon, Minji Allaway, Robert J. Kang, Jaewoo Park, Donghyeon Lee, Jinhyuk Jeon, Hwisang Ko, Miyoung Jiang, Hualiang Zheng, Mingyue Tan, Aik Choon Guo, Xindi Dang, Kristen K. Tropsha, Alex Hecht, Chana Das, Tirtha K. Carlson, Heather A. Abagyan, Ruben Guinney, Justin Schlessinger, Avner Cagan, Ross |
author_facet | Xiong, Zhaoping Jeon, Minji Allaway, Robert J. Kang, Jaewoo Park, Donghyeon Lee, Jinhyuk Jeon, Hwisang Ko, Miyoung Jiang, Hualiang Zheng, Mingyue Tan, Aik Choon Guo, Xindi Dang, Kristen K. Tropsha, Alex Hecht, Chana Das, Tirtha K. Carlson, Heather A. Abagyan, Ruben Guinney, Justin Schlessinger, Avner Cagan, Ross |
author_sort | Xiong, Zhaoping |
collection | PubMed |
description | A continuing challenge in modern medicine is the identification of safer and more efficacious drugs. Precision therapeutics, which have one molecular target, have been long promised to be safer and more effective than traditional therapies. This approach has proven to be challenging for multiple reasons including lack of efficacy, rapidly acquired drug resistance, and narrow patient eligibility criteria. An alternative approach is the development of drugs that address the overall disease network by targeting multiple biological targets (‘polypharmacology’). Rational development of these molecules will require improved methods for predicting single chemical structures that target multiple drug targets. To address this need, we developed the Multi-Targeting Drug DREAM Challenge, in which we challenged participants to predict single chemical entities that target pro-targets but avoid anti-targets for two unrelated diseases: RET-based tumors and a common form of inherited Tauopathy. Here, we report the results of this DREAM Challenge and the development of two neural network-based machine learning approaches that were applied to the challenge of rational polypharmacology. Together, these platforms provide a potentially useful first step towards developing lead therapeutic compounds that address disease complexity through rational polypharmacology. |
format | Online Article Text |
id | pubmed-8483411 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-84834112021-10-01 Crowdsourced identification of multi-target kinase inhibitors for RET- and TAU- based disease: The Multi-Targeting Drug DREAM Challenge Xiong, Zhaoping Jeon, Minji Allaway, Robert J. Kang, Jaewoo Park, Donghyeon Lee, Jinhyuk Jeon, Hwisang Ko, Miyoung Jiang, Hualiang Zheng, Mingyue Tan, Aik Choon Guo, Xindi Dang, Kristen K. Tropsha, Alex Hecht, Chana Das, Tirtha K. Carlson, Heather A. Abagyan, Ruben Guinney, Justin Schlessinger, Avner Cagan, Ross PLoS Comput Biol Research Article A continuing challenge in modern medicine is the identification of safer and more efficacious drugs. Precision therapeutics, which have one molecular target, have been long promised to be safer and more effective than traditional therapies. This approach has proven to be challenging for multiple reasons including lack of efficacy, rapidly acquired drug resistance, and narrow patient eligibility criteria. An alternative approach is the development of drugs that address the overall disease network by targeting multiple biological targets (‘polypharmacology’). Rational development of these molecules will require improved methods for predicting single chemical structures that target multiple drug targets. To address this need, we developed the Multi-Targeting Drug DREAM Challenge, in which we challenged participants to predict single chemical entities that target pro-targets but avoid anti-targets for two unrelated diseases: RET-based tumors and a common form of inherited Tauopathy. Here, we report the results of this DREAM Challenge and the development of two neural network-based machine learning approaches that were applied to the challenge of rational polypharmacology. Together, these platforms provide a potentially useful first step towards developing lead therapeutic compounds that address disease complexity through rational polypharmacology. Public Library of Science 2021-09-14 /pmc/articles/PMC8483411/ /pubmed/34520464 http://dx.doi.org/10.1371/journal.pcbi.1009302 Text en © 2021 Xiong et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Xiong, Zhaoping Jeon, Minji Allaway, Robert J. Kang, Jaewoo Park, Donghyeon Lee, Jinhyuk Jeon, Hwisang Ko, Miyoung Jiang, Hualiang Zheng, Mingyue Tan, Aik Choon Guo, Xindi Dang, Kristen K. Tropsha, Alex Hecht, Chana Das, Tirtha K. Carlson, Heather A. Abagyan, Ruben Guinney, Justin Schlessinger, Avner Cagan, Ross Crowdsourced identification of multi-target kinase inhibitors for RET- and TAU- based disease: The Multi-Targeting Drug DREAM Challenge |
title | Crowdsourced identification of multi-target kinase inhibitors for RET- and TAU- based disease: The Multi-Targeting Drug DREAM Challenge |
title_full | Crowdsourced identification of multi-target kinase inhibitors for RET- and TAU- based disease: The Multi-Targeting Drug DREAM Challenge |
title_fullStr | Crowdsourced identification of multi-target kinase inhibitors for RET- and TAU- based disease: The Multi-Targeting Drug DREAM Challenge |
title_full_unstemmed | Crowdsourced identification of multi-target kinase inhibitors for RET- and TAU- based disease: The Multi-Targeting Drug DREAM Challenge |
title_short | Crowdsourced identification of multi-target kinase inhibitors for RET- and TAU- based disease: The Multi-Targeting Drug DREAM Challenge |
title_sort | crowdsourced identification of multi-target kinase inhibitors for ret- and tau- based disease: the multi-targeting drug dream challenge |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483411/ https://www.ncbi.nlm.nih.gov/pubmed/34520464 http://dx.doi.org/10.1371/journal.pcbi.1009302 |
work_keys_str_mv | AT xiongzhaoping crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT jeonminji crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT allawayrobertj crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT kangjaewoo crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT parkdonghyeon crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT leejinhyuk crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT jeonhwisang crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT komiyoung crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT jianghualiang crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT zhengmingyue crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT tanaikchoon crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT guoxindi crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT dangkristenk crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT tropshaalex crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT hechtchana crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT dastirthak crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT carlsonheathera crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT abagyanruben crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT guinneyjustin crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT schlessingeravner crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge AT caganross crowdsourcedidentificationofmultitargetkinaseinhibitorsforretandtaubaseddiseasethemultitargetingdrugdreamchallenge |